Oxurion NV enters into a capital commitment of up to €30m with Negma Group by LLB Finance Reporter April 6, 2021 April 6, 2021
Oxford and AstraZeneca are making new vaccine for mutant strains by Mark Channer LLB Political Journalist February 3, 2021 February 3, 2021
Achilles therapeutics raises £52.7m in an oversubscribed Series C financing by LLB Finance Reporter November 19, 2020 November 19, 2020
Pfizer/BioNTech vaccine now 95% effective and meets safety criteria by LLB staff reporter November 18, 2020 November 18, 2020
Savanta ComRes: More than half ‘keen’ to have Pfizer Covid-19 vaccine by LLB staff reporter November 16, 2020 November 16, 2020
Second vaccine breakthrough which is more successful than Pfizer by LLB staff reporter November 16, 2020 November 16, 2020
